A director at Galapagos NV bought 95,856 shares at 33.260USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
Correction: Syensqo - Participation notification by BlackRock Inc. Participation notification by BlackRock Inc. Brussels, Belgium – July 28, 2025 - 8:30 CESTAccording to Belgian transparency legislation (Law of May 2, 2007), BlackRock Inc. (12 Throgmorton Avenue, London EC2N 2DL, UK) recently sent Syensqo the following transparency notifications indicating that it crossed the threshold of 3%. Here is the summary of the moves: Date on which the threshold was crossed Voting rights after the transaction Equivalent financial instruments after the transaction Total July 22 2025 3.02% ...
Correction: Syensqo - Notification de participation par BlackRock Inc. Notification de participation par BlackRock Inc. Bruxelles, Belgique – 28 juillet 2025 - 8:30 CEST Conformément à la législation et réglementation en matière de transparence financière (loi du 2 mai 2007), BlackRock Inc. (12 Throgmorton Avenue, London EC2N 2DL, UK) a envoyé à Syensqo une notification de transparence indiquant qu’il avait franchi le seuil de 3%. Voici un résumé des mouvements: Date à laquelle le seuil a été franchi Droits de vote après la transaction Instruments financiers équivalents après la tr...
Correction: Syensqo - Participatiemelding van BlackRock Inc. Participatiemelding van BlackRock Inc. Brussel, België - 28 juli 2025 – 8u30 CEST In overeenstemming met de Belgische wetgeving op de openbaring van belangrijke deelnemingen (wet van 2 mei 2007), heeft BlackRock Inc. (12 Throgmorton Avenue, London EC2N 2DL, UK) een transparantiemelding naar Syensqo gestuurd om aan te geven dat de drempel van 3% is overschreden. Hier vindt u de samenvatting van de bewegingen: Datum van drempeloverschrijding Stemrechten na de transactie Aan stemrechten gelijkgestelde financiële instrumenten ...
A director at Solvay SA bought 1,083 shares at 27.740EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
Alfen: Preview - muddling through? Belgian telcos: Competition Authority investigation on Proximus/Orange Belgium MoU. Brunel International: 2Q25 below, 3Q25 outlook cut, cost savings protect FY25 estimates. Euronext: Another record set of results. Fugro: Sharper V-shape? GBL: Weak NAV performance, as expected. KBC Ancora: Cooperative CERA increasing its stake to 51.24%, using excess cash. UCB: Renewed US threats to cut drug prices. Umicore: 1H25 and guide broadly in-line, new S...
AB InBev: 2Q25 results. Air France-KLM: Nice beat, let's see how FY25 finishes. AMG: Uptrend continues in 2Q25 with 23% EBITDA beat and guidance up to +US$200m. Aperam: Slight 2Q25 EBITDA beat, 3Q25 seen down QoQ. Arcadis: EBITA margin held up well in 2Q25, order intake mixed. Ayvens: 2Q25 results. Azelis: Soft but largely in-line 2Q25 with EMEA offsetting weaker APAC. Bekaert: 1H25 miss and lowered outlook to result in c.5% consensus downside. Corbion: Taking it to the wire. dsm...
2Q underlying EBITDA declined by 11% to € 335m, which was c.2% above our and consensus forecasts. Syensqo lowered FY25 underlying EBITDA guidance by c. € 100m to € 1.3bn to account for FX changes and tariffs. Despite the weak current earnings momentum, we believe that cost efficiency measures and portfolio streamlining should eventually be positive for the investment case. We continue to believe valuation is attractive and we reiterate our BUY rating and € 90 target price.
Syensqo launches the fourth tranche of its Share Buyback Program Syensqo launches the fourth tranche of its Share Buyback Program Brussels, Belgium – July 31, 2025 - 07:10 CET SYENSQO SA (the “Company”) announces today that pursuant to its Share Buyback Program (the “Program”) announced on September 30, 2024, covering up to €300 million, the Company launches the fourth tranche of this Program. This tranche of the Program will start on July 31, 2025 and will run until November 15 2025 at the latest, and will cover a maximum amount of up to € 50 million. It will be implemented under th...
Syensqo lance la quatrième tranche de son nouveau programme de rachat d'actions Syensqo lance la quatrième tranche de son nouveau programme de rachat d'actions Bruxelles, Belgique – 31 juillet 2025 - 07h10 CET SYENSQO SA (la “Société”) annonce aujourd'hui que conformément à son Programme de rachat d'actions (le ”Programme”) annoncé le 30 septembre 2024, couvrant jusqu'à €300 millions, la Société lance la quatrième tranche de ce Programme. Cette tranche du Programme débutera le 31 juillet 2025 et se poursuivra jusqu'au 15 novembre 2025 au plus tard, et portera sur un montant maximum de €...
Syensqo lanceert de vierde tranche van zijn aandeleninkoopprogramma Syensqo lanceert de vierde tranche van zijn aandeleninkoopprogramma Brussel, België - 31 juli 2025 – 17u45 CET SYENSQO SA (de “Vennootschap”) kondigt vandaag aan dat in het kader van het aandeleninkoopprogramma (of het “Programma”) dat werd aangekondigd op 30 september 2024 en dat betrekking heeft op maximaal €300 miljoen, de Vennootschap de vierde tranche van dit programma lanceert. Deze tranche van het Programma gaat van start op 31 juli 2025 loopt tot uiterlijk 15 november 2025, en dekt een maximumbedrag van € 50 milj...
Syensqo - Résultats du Second Trimestre 2025 RÉSULTATS DE DU DEUXIÈME TRIMESTRE 2025 31 juillet 2025 à 7h00 CEST L’EBITDA SOUS-JACENT DE €335 MILLIONS, EN HAUSSE DE 8% SÉQUENTIELLEMENT AMÉLIORATION DE LA MARGE DANS LES PRINCIPAUX SEGMENTS D'ACTIVITÉ PERSPECTIVES 2025 MISES À JOUR POUR LES IMPACTS DES TAUX DE CHANGE ET DES DROITS DE DOUANE Faits marquants T2 2025 Chiffre d’affaires net de €1,59 milliard, impacté par des effets de change défavorables d’une année sur l’autre (-4%) et des volumes en baisse (-3%), tandis que les prix sont restés globalement stables ; Croissance d’une anné...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.